<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04826120</url>
  </required_header>
  <id_info>
    <org_study_id>Epidural in Labor</org_study_id>
    <nct_id>NCT04826120</nct_id>
  </id_info>
  <brief_title>Continuous Versus Intermittent Administration of Epidural Analgesia During Labor</brief_title>
  <official_title>Continuous Versus Intermittent Administration of Epidural Analgesia During Labor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mongi Slim Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mongi Slim Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      prospective randomized single blind study, including full term adult parturients, ASA 2, 3&#xD;
      status, scheduled for vaginal delivery. patients were randomized at 3 cm of cervix&#xD;
      dilatation, into 2 groups.&#xD;
&#xD;
      Epidural analgesia was initiated and maintained with a solution of Bupivacaine 0,125% and&#xD;
      Sufentanil 0,25 mcg/ml. After an initial bolus of 16 ML, patients were randomly assigned to&#xD;
      receive intermittent boluses of 8 ml every 60 minutes after the initial dose followed by&#xD;
      supplementary PCEA boluses of 8 ml for the first group ( PCEA group) or a continuous epidural&#xD;
      infusion at the rate of 8 ml/h adjustable and starting immediately after The initial bolus of&#xD;
      16 ml for patients of the second group (CEI Group).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      prospective randomized single blind study, including full term adult parturients, ASA 2, 3&#xD;
      status, scheduled for vaginal delivery. patients were randomized at 3 cm of cervix&#xD;
      dilatation, into 2 groups.&#xD;
&#xD;
      Epidural analgesia was initiated and maintained with a solution of Bupivacaine 0,125% and&#xD;
      Sufentanil 0,25 mcg/ml. After an initial bolus of 16 ML, patients were randomly assigned to&#xD;
      receive intermittent boluses of 8 ml every 60 minutes after the initial dose followed by&#xD;
      supplementary PCEA boluses of 8 ml for the first group ( PCEA group) or a continuous epidural&#xD;
      infusion at the rate of 8 ml/h adjustable and starting immediately after The initial bolus of&#xD;
      16 ml for patients of the second group (CEI Group).&#xD;
&#xD;
      The main outcome of this study was: the incidence of motor Blockage. Our secondary outcomes&#xD;
      were: maternal satisfaction, local anaesthetic and sufentanil cumulated doses, duration of&#xD;
      the second stage of labor, mode of delivery and pain during labor using the Visual analogic&#xD;
      score (VAS score).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Actual">January 31, 2021</completion_date>
  <primary_completion_date type="Actual">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>parturients randomized in 2 groups and receiving 2 different interventions</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of motor Blockage</measure>
    <time_frame>during the epidural analgesia</time_frame>
    <description>Bromage scale 1, 2 or 3</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Epidural; Analgesia</condition>
  <arm_group>
    <arm_group_label>PCEA group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients of this group had intermittent epidural analgesia via PCEA associated to systematic 8 ml boluses every 60 min during the second stage of labor.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CEI Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients of this group had continuous epidural infusion at the rate of 8 ml/h during the second stage of labor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PCEA Infusion</intervention_name>
    <description>Patients of this group Had PCEA during the second stage of labor</description>
    <arm_group_label>PCEA group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous epidural infusion</intervention_name>
    <description>Patients of this group Had continuous epidural infusion during the second stage of labor</description>
    <arm_group_label>CEI Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Full term parturients scheduled for vaginal delivery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients in whom cesarean section delivery was indicated during labor&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>parturients scheduled for vaginal delivery</gender_description>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mongi Slim University Hospital</name>
      <address>
        <city>La Marsa</city>
        <state>Tunis</state>
        <zip>2046</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mongi Slim Hospital</name>
      <address>
        <city>Tunis</city>
        <zip>2046</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 26, 2021</study_first_submitted>
  <study_first_submitted_qc>March 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>March 30, 2021</last_update_submitted>
  <last_update_submitted_qc>March 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mongi Slim Hospital</investigator_affiliation>
    <investigator_full_name>Mhamed Sami Mebazaa</investigator_full_name>
    <investigator_title>Professor, head of department of anesthesia and critical care</investigator_title>
  </responsible_party>
  <keyword>Epidural, Analgesia, Labor, delivery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

